Abstract
AB0528 COMPARABLE SAFETY PROFILE OF GUSELKUMAB IN PSORIATIC ARTHRITIS AND PSORIASIS: RESULTS FROM PHASE 3 TRIALS THROUGH 1 YEAR
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1136/annrheumdis-2021-eular.556
Copy DOIJournal: Annals of the Rheumatic Diseases | Publication Date: May 19, 2021 |
Citations: 1 |
AB0528 COMPARABLE SAFETY PROFILE OF GUSELKUMAB IN PSORIATIC ARTHRITIS AND PSORIASIS: RESULTS FROM PHASE 3 TRIALS THROUGH 1 YEAR
Join us for a 30 min session where you can share your feedback and ask us any queries you have